Abstract
The biomarker development field within molecular medicine remains limited by the methods that are available for building predictive models. We developed an efficient method for conservatively estimating confidence intervals for the cross validation-derived prediction errors of biomarker models. This new method was investigated for its ability to improve the capacity of our previously developed method, StaVarSel, for selecting stable biomarkers. Compared with the standard cross validation method, StaVarSel markedly improved the estimated generalisable predictive capacity of serum miRNA biomarkers for the detection of disease states that are at increased risk of progressing to oesophageal adenocarcinoma. The incorporation of our new method for conservatively estimating confidence intervals into StaVarSel resulted in the selection of less complex models with increased stability and improved or similar predictive capacities. The methods developed in this study have the potential to improve progress from biomarker discovery to biomarker driven translational research.
Original language | English |
---|---|
Article number | 7068 |
Number of pages | 16 |
Journal | International Journal of Molecular Sciences |
Volume | 24 |
Issue number | 8 |
DOIs | |
Publication status | Published - Apr 2023 |
Keywords
- Barrett’s oesophagus
- bias–variance trade-off
- biomarkers
- cross validation
- machine learning
- microRNA
- miRNA
- oesophageal adenocarcinoma
- robustness
- stability